NIDDK NIH Summary Report Charcot Workshop, co-sponsored by NIH’s Office of Rare Diseases (2008), http://archives.niddk.nih.gov/neuroarthropathy/SummaryReport.pdf,/neuroarthropathy/summaryreport.pdf
Sohn M-W, Lee Todd A, Stuck R, Frykberg R, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of dibaetic foot ulcer and diabetes alone. Diabetes Care. 2009;32:816–21.
Article
PubMed Central
PubMed
Google Scholar
Rogers L, Frykberg R, Armstrong D, Boulton A, Edmonds M, Georges H, et al. The Charcot Foot in Diabetes. Diabetes Care. 2011;34(9):2123–9.
Article
PubMed Central
PubMed
Google Scholar
Wukich D, Sung W, Wipf AM, Armstrong D. The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011;28:195–8.
Article
CAS
PubMed
Google Scholar
Eichenholtz SN. Charcot Joints. IL, USA: Springfield; 1966. Charles C. Thomas.
Google Scholar
Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am. 1990;72:749–56.
CAS
PubMed
Google Scholar
Sella E, Barrette C. Staging of Charcot Neuroarthropathy Along the Medial Column of the Foot in the Diabetic Patient. J Foot Ankle Surg. 1999;38(1):34–40.
Article
CAS
PubMed
Google Scholar
Ndip A, Williams A, Jude E, Serracino-Inglott F, Richardson S, Smyth JV, et al. The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy. Diabetes. 2011;60(8):2187–96.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wukich D, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009;23(6):409–26.
Article
PubMed
Google Scholar
Pakarinen TK, Laine J, Honkonen E, Peltonen J, Oksala H, Lahtela J. Charcot Arthropathy of the Diabetic Foot. Current Concepts and Review of 36 Cases. Scand J Surg. 2002;91(2):195–201.
CAS
PubMed
Google Scholar
Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Family Physcian. 2001;64:1591–8.
Sinha S, Munichoodappa C, Kozak G. Neuroarthropathy (Charcot Joints) In Diabetes Mellitus. Medicine. 1972;51(3):191–210.
Article
CAS
PubMed
Google Scholar
Fabrin J, Larsen K, Holstein PE. Long term follow up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):6796–800.
Article
Google Scholar
Lavery L, Armstrong D, Wunderlich R, Tredwell J, Boulton A. Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26(5):1435–8.
Article
PubMed
Google Scholar
Koeck FX, Bobrik V, Fassold A, Grifka J, Kessler S, Straub R. Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res. 2009;27(6):736–41.
Article
PubMed
Google Scholar
Mabilleau G, Petrova N, Edmonds ME, Sabokbar A. Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-alpha are Raised in Acute Charcot Foot. Diabetes Care. 2011;34(3):33.
Article
Google Scholar
Frykberg R, Belczyk R. Epidemiology of the Charcot Foot. Clin Podiatr Med Surg. 2008;25(1):17–28.
Article
PubMed
Google Scholar
Petrova NL, Foster VM, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Diabet Med. 2005;22:756–61.
Article
CAS
PubMed
Google Scholar
Matricali GA, Bammens B, Kuypers D, Flour M, Mathieu C. Diabetic Nephropathy but not HbA1c is predictive for frequent complications of Charcot feet –long term follow up of 164 patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes. 2012;120(30):335–9.
Google Scholar
Samann A. Diabetic Nephropathy but not HbA1c is predictive for frequent complications of Charcot feet –long term follow up of 164 patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes. 2012;120(30):335–9.
CAS
PubMed
Google Scholar
Munson M, Wrobel J, Holmes C, Hanauer D. Data Mining for Identifying Novel Associations amnd Temporal Relationships with Charcot Foot. J Diabetes Res. 2014;2014:214353.
Article
PubMed Central
PubMed
Google Scholar
Wrobel JS, Mayfield J, Reibar G. Geographic Variation of Lower-Extremity Major Amputation in Individuals With and Without Diabetes in the Medicare Population. Diabetes Care. 2001;24(5):860–4.
Article
CAS
PubMed
Google Scholar
Sohn MW, Stuck R, Pinzur M, Lee T, Budiman-Mak E. Lower-Extremity Amputation Risk after Charcot Arthropathy and Diabetic Foot Ulcer. Diabetes Care. 2010;33:98–100.
Article
PubMed Central
PubMed
Google Scholar
Rogers L, Bevilacqua N. Imaging of the Charcot Foot. Clin Podiatr Med Surg. 2008;25:43–51.
Article
PubMed
Google Scholar
Rogers L, Frykberg R. The Charcot Foot. Med Clin N Am. 2013;97:847–56.
Article
PubMed
Google Scholar
Sanders LJ, Mrdjenovich D. Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes. 1991;40 Suppl 1:529A.
Google Scholar
Sanders LJ, Frykberg RG. Diabetic Neuropathic Osteoarthropathy: The Charcot Foot, 297–338. In: Frykberg RG, editor. The High Risk Foot In Diabetes Mellitus. New York: Churchill Livingstone; 1991.
Google Scholar
Armstrong D, Lavery L. The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14:357–63.
Article
CAS
PubMed
Google Scholar
Armstrong DG, Lavery LA, Liswood PJ, Todd WF, Tredwell JA. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther. 1997;77(2):169–75. discussion 176–7.
CAS
PubMed
Google Scholar
Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy-current standards. Diabetes Metab Res Rev. 2008;24 Suppl 1:S58–61.
Article
PubMed
Google Scholar
Wrobel JS, Connolly JE, Beach ML. Associations between static and functional measures of joint function in the foot and ankle. J Am Podiatr Med Assoc. 2004;94(6):535–41.
Article
PubMed
Google Scholar
Armstrong DG, Lavery LA. Monitoring healing of acute Charcot’s arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317–21.
CAS
PubMed
Google Scholar
Najafi B, Wrobel JS, Grewal G, Menzies RA, Talal TK, Zirie M, et al. Plantar Temperature Response to Walking in Diabetes with and without Acute Charcot: The Charcot Activity Response Test. J Aging Res. 2012;2012:140968.
Article
PubMed Central
PubMed
Google Scholar
Najafi B, Crews RT, Wrobel JS. The Importance of Time Spent Standing for those at Risk of Diabetic Foot Ulceration. Diabetes Care. 2010;33(11):2448–50.
Article
PubMed Central
PubMed
Google Scholar
Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot Arthropathy Risk Elevation in the Obese Diabetic Population. Am J Med. 2008;121(11):1008–14.
Article
PubMed
Google Scholar
Geschickter CF, Cannon A. Colour Atlas of Pathology: Central Nervous System. London, Philadelphia: Pitman Medical Publishing Co. Ltd; 1963. Lippingcott.
Google Scholar
La Fontaine J, Shibuya N, Sampson W, Valderrama P. Trabecular Quality and Cellular Characteristics of Normal, Diabetic, and Charcot Bone. J Foot Ankle Surg. 2011;50:648–53.
Article
PubMed
Google Scholar
Chantelau E, Gruetzner G. Is the Eichenholtz classification still valid for the diabetic Charcot Foot? Swiss Med Wkly. 2014;144:w13948. The European Journal of Medical Sciences.
PubMed
Google Scholar
Palestro CJ, Love C, Tronco GG, Tomas JN, Rini JN. Combined Labeled Leukocyte and Technetium 99 m Sulfur Colloid Bone Marrow Imaging for Diagnosing Musculoskeletal Infection 1. RadioGraphics. 2006;26:859–70.
Article
PubMed
Google Scholar
Van Nostrand D, Abreu SH, Callaghan JJ, Atkins FB, Stoops HC, Savory CG. In-111–labeled white blood cell uptake in noninfected closed fracture in humans: prospective study. Radiology. 1988;167:495–8.
Article
PubMed
Google Scholar
Hayashida K, Ochi T, Fujimoto M, Owaki H, Shimaoka Y, Ono K, et al. Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis. Arthritis Rheum. 1992;35:241–5. 660. 15.
Article
CAS
PubMed
Google Scholar
Rosenberg AE. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia, Pa: Elsevier Saunders; 2005. p. 1273–324.
Google Scholar
Littenberg B, Mushlin A. Technetium Bone Scanning in the Diagnosis of Osteomyelitis: A Meta-analysis of Test Performance. J Gen Intern Med. 1992;7:158–63.
Article
CAS
PubMed
Google Scholar
Schauwecker DS. The scintigraphic diagnsosi of osteomyelitis. Am J Roentgenol. 1992;158:9–18.
Article
CAS
Google Scholar
Thakur ML, Lavender R, Silvester D, Segal A. Indium 111 Labeled Autologous Leukocytes in Man. J Nuc Med. 1977;18:1014–21.
CAS
Google Scholar
Boc SF, Brazzo K, Lavian D. Acute Charcot foot changes versus osteomyelitis: does Tc-99 m HMPAO labeled leukocytes scan differentiate? JAPMA. 2001;7(91):365–8.
Google Scholar
Morbach H, Schneider P, Schwarz T, Hofmann C, Neubauer H, Duren C, et al. Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin Exp Rheumatol. 2012;30:578–82.
PubMed
Google Scholar
Palestro CJ, Mehta MM, Patel M, Freemanm SJ. Marrow versus infection in the Charcot joint: Indium-Ill leukocyte and technetium-99 m sulfur colloid scintigraphy. J Nucl Med. 1998;39:346–50.
CAS
PubMed
Google Scholar
Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med. 1997;27:334–45.
Article
CAS
PubMed
Google Scholar
Milne T, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, Quinton TR, et al. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review. J Foot Ankle Res. 2013;6:30.
Article
PubMed Central
PubMed
Google Scholar
Irie K. Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech. 2002;58:85–90.
Article
CAS
PubMed
Google Scholar
Burns PR. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle. 2012. doi:10.3402/dfa.v3i0.12236.
Google Scholar
Weitzmann NM. The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica. 2013;2013:125705. doi:10.1155/2013/125705.
Article
PubMed Central
PubMed
Google Scholar
Mabilleau G. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia. 2008;51:1035–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sinha S, Munichoodappa C, Kozak G. Neuro-arthropathy (Charcot joints) in diabetes mellitus. Medicine. 1971;51:191–210.
Article
Google Scholar
Cofield RH, Motrisin M, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic changes. Foot Ankle Int. 1983;4:15–22.
Article
CAS
Google Scholar
Sanders L, Frykberg R. Charcot neuroathropathy of the foot. In: Bowker J, Pfeifer M, editors. The Diabetic Foot. 6th ed. Mosby: St. Louis; 2001. p. 439–66.
Google Scholar
Rajbhandari SJ, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.
Article
CAS
PubMed
Google Scholar
Hartemann-Heurtier A, Van Ha G, Grimaldi A. The Charcot foot. Lancet. 2002;360:1776–9.
Article
PubMed
Google Scholar
Rogers L, Bevilacqua N. The Diagnosis of Charcot Foot. Clin Podiatr Med Surg. 2008;25:43–51.
Article
PubMed
Google Scholar